BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25922883)

  • 1. Rapid generation of endogenously driven transcriptional reporters in cells through CRISPR/Cas9.
    Rojas-Fernandez A; Herhaus L; Macartney T; Lachaud C; Hay RT; Sapkota GP
    Sci Rep; 2015 Apr; 5():9811. PubMed ID: 25922883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of Endogenous BMP Transcriptional Reporter Cells Through CRISPR/Cas9 Genome Editing.
    Hutchinson LD; Bozatzi P; Macartney T; Sapkota GP
    Methods Mol Biol; 2019; 1891():29-35. PubMed ID: 30414124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.
    Schwartz C; Wheeldon I
    Methods Mol Biol; 2018; 1772():327-345. PubMed ID: 29754237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a novel HEK293 luciferase reporter cell line by CRISPR/Cas9-mediated site-specific integration in the genome to explore the transcriptional regulation of the PGRN gene.
    Li Y; Li S; Li Y; Xia H; Mao Q
    Bioengineered; 2019 Dec; 10(1):98-107. PubMed ID: 31023186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Genome-Editing Tools to Develop a Novel In Situ Coincidence Reporter Assay for Screening ATAD3A Transcriptional Inhibitors.
    Lang L; Teng Y
    Methods Mol Biol; 2020; 2138():159-166. PubMed ID: 32219745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair.
    He X; Tan C; Wang F; Wang Y; Zhou R; Cui D; You W; Zhao H; Ren J; Feng B
    Nucleic Acids Res; 2016 May; 44(9):e85. PubMed ID: 26850641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional visualization and disruption of targeted genes using CRISPR/Cas9-mediated eGFP reporter integration in zebrafish.
    Ota S; Taimatsu K; Yanagi K; Namiki T; Ohga R; Higashijima SI; Kawahara A
    Sci Rep; 2016 Oct; 6():34991. PubMed ID: 27725766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9-based genome engineering of zebrafish using a seamless integration strategy.
    Luo JJ; Bian WP; Liu Y; Huang HY; Yin Q; Yang XJ; Pei DS
    FASEB J; 2018 Sep; 32(9):5132-5142. PubMed ID: 29812974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a DGKθ Endogenous Promoter Luciferase Reporter HepG2 Cell Line for Studying the Transcriptional Regulation of DGKθ Gene.
    Shan L; Wang D; Mao Q; Xia H
    Appl Biochem Biotechnol; 2019 Apr; 187(4):1344-1355. PubMed ID: 30229432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of Gene-Edited Chrysanthemum morifolium Using Multicopy Transgenes as Targets and Markers.
    Kishi-Kaboshi M; Aida R; Sasaki K
    Plant Cell Physiol; 2017 Feb; 58(2):216-226. PubMed ID: 28049122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence Marker-Assisted Isolation of Cas9-Free and CRISPR-Edited Arabidopsis Plants.
    Yu H; Zhao Y
    Methods Mol Biol; 2019; 1917():147-154. PubMed ID: 30610634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy.
    Potts MA; McDonald JA; Sutherland KD; Herold MJ
    Eur J Immunol; 2020 Dec; 50(12):1871-1884. PubMed ID: 33202035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
    Grenier F; Lucier JF; Rodrigue S
    Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
    Ahmad G; Amiji M
    Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted editing of transcriptional activator MXR1 on the Pichia pastoris genome using CRISPR/Cas9 technology.
    Hou C; Yang Y; Xing Y; Zhan C; Liu G; Liu X; Liu C; Zhan J; Xu D; Bai Z
    Yeast; 2020 Apr; 37(4):305-312. PubMed ID: 32050051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model.
    Li R; Xia X; Wang X; Sun X; Dai Z; Huo D; Zheng H; Xiong H; He A; Wu X
    PLoS Biol; 2020 Nov; 18(11):e3000749. PubMed ID: 33253175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
    Vermersch E; Jouve C; Hulot JS
    Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient Editing of the Nuclear
    Guzmán-Zapata D; Sandoval-Vargas JM; Macedo-Osorio KS; Salgado-Manjarrez E; Castrejón-Flores JL; Oliver-Salvador MDC; Durán-Figueroa NV; Nogué F; Badillo-Corona JA
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5S rRNA Promoter for Guide RNA Expression Enabled Highly Efficient CRISPR/Cas9 Genome Editing in
    Zheng X; Zheng P; Zhang K; Cairns TC; Meyer V; Sun J; Ma Y
    ACS Synth Biol; 2019 Jul; 8(7):1568-1574. PubMed ID: 29687998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome and epigenome engineering CRISPR toolkit for
    Williams RM; Senanayake U; Artibani M; Taylor G; Wells D; Ahmed AA; Sauka-Spengler T
    Development; 2018 Feb; 145(4):. PubMed ID: 29386245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.